This is a preview of subscription content, log in via an institution to check access.
Reference
Sculpher M, et al. After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator? PharmacoEconomics : 13 Jan 2020. Available from: URL: http://doi.org/10.1007/s40273-019-00882-6
Rights and permissions
About this article
Cite this article
NICE's 2019/2020 methods review: challenges and opportunities. PharmacoEcon Outcomes News 846, 2 (2020). https://doi.org/10.1007/s40274-020-6541-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6541-y